Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium)

NCT00951574 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1166

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Cancer
Metastatic Cancer

Interventions

DRUG: Nadroparin calcium
DRUG: saline solution (placebo)

Sponsor

Italfarmaco